Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Taking a Glimpse Into the Brain's Immune System: Imaging and Blood-Based Biomarkers of the Poststroke Immune Response.

Stroke·2026

Same author

Association between aldehyde dehydrogenase 4 family member A1 plasma concentrations and atherosclerotic disease in patients with ischemic stroke: Results from the prospective multicenter BIOSIGNAL study.

Clinica chimica acta; international journal of clinical chemistry·2026

Same author

Assessing optic nerve integrity in optic neuritis with conventional magnetic resonance imaging.

AJNR. American journal of neuroradiology·2026

Same author

Biomarkers for advancing diagnosis and prognosis in stroke.

The Lancet. Neurology·2026

Same author

Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis.

Human brain mapping·2026

Same author

Assessing the cervical canal area in multiple sclerosis with spinal cord sagittal 2D T2-weighted sequences.

Magma (New York, N.Y.)·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

H-FABP as a Biomarker in Transient Ischemic Attack.

Daisy Guamán-Pilco¹, Elvira Chocano¹, Elena Palà¹

¹Neurovascular Research Laboratory Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Journal of Cardiovascular Translational Research

|August 19, 2024

Summary

Heart fatty-acid binding protein (H-FABP) shows promise in differentiating transient ischemic attacks (TIA) from similar conditions. Elevated H-FABP levels in TIA patients suggest its utility as a rapid diagnostic biomarker in clinical settings.

Keywords:

Biomarker Diagnostic H-FABP Ischemia MIMIC POCT TIA

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Related Experiment Videos

Last Updated: Jun 16, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Area of Science:

Cardiology
Neurology
Biomarker Discovery

Background:

Transient ischemic attack (TIA) diagnosis can be challenging, often requiring differentiation from conditions with similar symptoms.
Accurate and rapid diagnostic tools are crucial for timely TIA management and stroke prevention.

Purpose of the Study:

To evaluate the effectiveness of heart fatty-acid binding protein (H-FABP) as a biomarker for distinguishing TIA from its mimics.
To assess the diagnostic performance of H-FABP using a point-of-care test (POCT).

Main Methods:

Retrospective analysis of 175 patients from the StrokeChip multicenter study.
Measurement of H-FABP levels using a rapid point-of-care test.
Statistical analysis including ROC curve analysis to determine diagnostic accuracy.

Main Results:

H-FABP levels were significantly higher in patients with TIA compared to those with mimics (p < 0.001).
The area under the curve (AUC) for the final model was 0.83, indicating good discriminative ability.
A combined model using H-FABP, age, and NIHSS achieved 100% sensitivity for TIA detection.

Conclusions:

H-FABP demonstrates potential as a valuable biomarker for the rapid diagnosis of TIA.
The use of POCT for H-FABP measurement supports its applicability in emergency departments and primary care.